Alyeska Investment Group, L.P. - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 30 filers reported holding APTEVO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$3,122,000
-86.0%
139,172
-80.9%
0.04%
-87.5%
Q1 2021$22,286,000
+1125.9%
730,232
+1372.2%
0.29%
+1007.7%
Q4 2020$1,818,000
-66.3%
49,601
-92.3%
0.03%
-68.3%
Q2 2020$5,394,000
+94.4%
645,982
-13.9%
0.08%
+49.1%
Q1 2020$2,775,000750,0000.06%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
CANTOR FITZGERALD, L. P. 215,200$4990.01%
Schonfeld Strategic Advisors LLC 142,100$329,6720.00%
TWO SIGMA SECURITIES, LLC 14,877$34,5150.00%
FIFTH THIRD BANCORP 291$6750.00%
FRANKLIN RESOURCES INC 10,997$25,5130.00%
BANK OF AMERICA CORP /DE/ 11$260.00%
PNC FINANCIAL SERVICES GROUP, INC. 142$3290.00%
MONEY CONCEPTS CAPITAL CORP 7$160.00%
WELLS FARGO & COMPANY/MN 1,613$3,7420.00%
NORTHERN TRUST CORP 17,338$40,2240.00%
View complete list of APTEVO THERAPEUTICS INC shareholders